Go to main content

Press Releases

Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com 

AOP Orphan supports Rare Disease Awareness Day 2021

1. 3. 2021

European ICU drug supports patients in Canada

1. 2. 2021

AOP Orphan: PAH Treatment for patients in Argentina

26. 1. 2021

AOP Orphan announces five-year results on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia vera at the American Society of Hematology (ASH) Annual Meeting 2020

7. 12. 2020

ICC ruled in favor of AOP Orphan Pharmaceuticals AG in arbitration proceedings pertaining to BESREMi® (Ropeginterferon alpha-2b)

27. 10. 2020

Rare disease pioneer AOP Orphan takes over two health care companies, strengthening its position in Europe as well as Vienna as a research- and business hub.

12. 10. 2020